Ovid Therapeutics Inc.

0.73
-0.00 (-0.25%)
At close: Jan 28, 2025, 1:51 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 391.69K 1.50M 208.38M 12.62M n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 1.38M n/a n/a 255.00K 141.73K 80.31K 56.51K 11.78K n/a
Gross Profit 391.69K 121.14K 208.38M 12.62M -255.00K -141.73K -80.31K -56.51K -11.78K n/a
Operating Income -59.28M -55.55M 124.21M -81.43M -61.41M -52.93M -65.01M -22.54M -13.19M -446.89K
Interest Income 4.90M n/a n/a 395.40K 948.22K 952.07K 201.51K n/a 30.28K n/a
Pretax Income -52.34M -54.17M 124.16M -81.04M -60.46M -51.98M -64.81M -22.41M -13.16M -446.89K
Net Income -52.34M -51.41M 122.83M -80.73M -59.26M -51.98M -64.81M -22.41M -13.16M -446.89K
Selling & General & Admin 31.09M 32.43M 37.23M 30.63M 19.25M 19.14M 15.04M 12.95M 6.58M 341.52K
Research & Development 28.59M 24.62M 46.94M 63.42M 42.16M 33.79M 49.97M 9.59M 6.61M 105.38K
Other Expenses 1.00 1.38M -45.69K 395.40K n/a n/a n/a n/a n/a n/a
Operating Expenses 59.67M 57.05M 84.17M 94.05M 61.41M 52.93M 65.01M 22.54M 13.19M 446.89K
Interest Expense n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses 59.67M 57.05M 84.17M 94.05M 61.41M 52.93M 65.01M 22.54M 13.19M 446.89K
Income Tax n/a -2.76M 1.33M -306.85K -1.20M 951.73K -80.31K -950 n/a n/a
Shares Outstanding (Basic) 70.58M 70.42M 67.48M 58.45M 39.22M 24.63M 19.34M 19.60M 19.60M 4.75M
Shares Outstanding (Diluted) 70.58M 70.42M 68.07M 58.45M 39.22M 24.63M 19.34M 19.60M 19.60M 4.75M
EPS (Basic) -0.74 -0.73 1.78 -1.38 -1.51 -2.11 -3.35 -1.14 -0.67 -0.09
EPS (Diluted) -0.74 -0.73 1.78 -1.38 -1.51 -2.11 -3.35 -1.14 -0.67 -0.09
EBITDA -57.69M -52.79M 124.40M -81.12M -60.21M -52.79M -64.73M -22.48M -13.18M -444.58K
Depreciation & Amortization 1.60M 1.38M 237.00K 307.00K 255.00K 141.73K 80.31K 56.51K 11.78K 2.31K